Phase II
Recruitment :
Start 01/01/2012
End 04/12/2012
Location of trial : CLOSED .
********************************************
Please note - this trial is no longer recruiting patients. We hope to add results when they are available.
This trial is looking at a new drug PM01183 to treat pancreatic cancer that has spread to other parts of the body.
Pancreatic cancer that has spread to other parts of the body is sometimes called advanced pancreatic cancer. Doctors usually treat this with chemotherapy including the drug gemcitabine. Sadly this doesn’t always work very well so doctors want to find new drugs to help people with advanced pancreatic cancer.
PM01183 is a new drug that affects how cancer cells divide and grow. Researchers want to find out if it can help people with advanced pancreatic cancer.
The aim of this trial is to find out
*.- If PM01183 can help people with advanced pancreatic cancer that has come back or did not go away with chemotherapy
*.- About the side effects
The Information Nurses
Cancer Research UK
Angel Building
407 St John Street , London
EC1V 4AD
Chief Investigator : Dr David Cunningham
Supported by Pharma Mar .